Boston Trust Walden Corp trimmed its holdings in Johnson & Johnson (NYSE:JNJ) by 2.2% in the second quarter, according to a recent SEC filing.
The fund owned 580,833 shares of the company's stock after selling 13,228 shares during the period.
Johnson & Johnson accounts for about 1.1% of Boston Trust Walden Corp's investment portfolio, making the stock its 12th biggest holding.
More on Stocks
Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.
Market sentiment intelligence for apps, funds & agents
Location
729 55 Ave SW
Calgary AB T2V 0G4
Canada
© 2026 Guavy Inc
